The Animal By-Products and Transmissible Spongiform Encephalopathies (Amendment) (Northern Ireland) (EU Exit) Regulations 2019

Amendment to the Transmissible Spongiform Encephalopathies Regulations (Northern Ireland) 2018N.I.

This section has no associated Explanatory Memorandum

4.—(1) The Transmissible Spongiform Encephalopathies Regulations (Northern Ireland) 2018 M1 are amended as follows.

F1(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F1(3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(4) In Schedule 2, for paragraph 11(2) substitute—

(2) In this Schedule an “approved testing laboratory” means—

(a)a laboratory approved by the Department under this paragraph; or

(b)a laboratory approved under corresponding legislation elsewhere in the United Kingdom.

F2(5) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(6) In Schedule 7—

(a)in paragraph 1, omit “placed on the member State”;

F3(b). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F3(c). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F3(d). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F4(7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .